Quan Dong Nguyen
Quan Dong Nguyen is an expert in Ophthalmology at Stanford University (United States). As of October 2026, ScienceLeadR ranks Quan Dong Nguyen in the top 1% of experts worldwide for Uveitis, Uveal Diseases and Retinal Diseases. Quan Dong Nguyen has authored 668 publications, the most recent in 2026, and is an investigator in 29 clinical trials, 2 of them ongoing. SLR score: 2,382 (community average: 125). How the SLR is computed.
LeadR Profile
Ophthalmology
Subspecialties: Immunology - Internal Medicine - Medical Imaging
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2004 - 2026
Number : 668
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Ocular Adverse Events Associated With Dupilumab: Analysis From a Real-World Database. PMID 42766442 — dermatitis, cornea, propensity score, drug-related side effects and adverse reactions, conjunctivitis, keratitis, blepharitis, dermatitis, atopic | Cornea | 2026 | 0 |
| Imaging of Multifocal Adenoid Cystic Carcinoma of the Breast Initially Diagnosed as Adenomyoepithelioma on Core Needle Biopsy: A Case Report. PMID 42732445 — carcinoma, adenoid cystic, adenomyoepithelioma, biopsy, biopsy, large-core needle, biopsy, needle, carcinoma, intraductal, noninfiltrating, breast, hyperplasia, wounds and injuries, needles, adenoids | Cureus | 2026 | 0 |
| Spectral-Domain Optical Coherence Tomography Morphological Characteristics in Patients with Cone Dysfunction Disorders: A Retrospective Case Series. PMID 42703570 — eye, cone dystrophy, atrophy, tomography, visual acuity, tomography, optical coherence, retinaldehyde | Clin Ophthalmol | 2026 | 0 |
| Evidence and Consensus Based Imaging Guidelines in Ocular Toxoplasmosis. Multimodal imaging in Uveitis (MUV) Taskforce Report 14. PMID 42685929 — retinitis, ophthalmology, retina, toxoplasmosis, angiography, toxoplasmosis, ocular, multimodal imaging, tomography, optical coherence, diagnosis, retinaldehyde, uveitis | Ophthalmol Retina | 2026 | 0 |
| Pooled Analyses of Anatomic and Visual Function Data of Revakinagene Taroretcel-lwey in Participants with Macular Telangiectasia Type 2. PMID 42476337 — eye, reading, ophthalmology, telangiectasis, retinaldehyde | Ophthalmol Retina | 2026 | 0 |
Clinical Studies 29
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Safety Tolerability and Distribution of Laquinimod Eye Drops The LION Study NCT06161415 — eye, receptors, aryl hydrocarbon, immunomodulation, safety, solutions, ophthalmic solutions, hydrocarbons, uveitis | Phase 1 | Recruiting | 2024 |
| Multicenter Study on the Efficacy and Safety of OCS 01 in Subjects With Uveitis Related and Post Surgical Macular Edema NCT05608837 — eye, anti-inflammatory agents, vision, ocular, safety, suspensions, pharmaceutical preparations, dexamethasone, macular edema, retinal diseases, retinaldehyde, uveitis, edema | Phase 2 | Active not recruiting | 2023 |
LeadR Networks
Main global connection map